SXTP

0.80

24.53% -0.26

Handel nachbörslich: .78 -0.02 -2.50%

60 Degrees Pharmaceuticals Inc (SXTP)

Überblick Nachrichten Preisverlauf Warum fällt SXTP? Forum Prognose

Schlusskurs vom Vortag:

$1.06

Offen:

$0.9656

24-Stunden-Volumen:

2.68M

Relative Volume:

1.81

Marktkapitalisierung:

$1.84M

Einnahmen:

$502.40K

Nettoeinkommen (Verlust:

$-7.91M

KGV:

-0.0802

EPS:

-9.972

Netto-Cashflow:

$-4.32M

1W Leistung:

-8.98%

1M Leistung:

-37.01%

6M Leistung:

-59.58%

1J Leistung:

-78.31%

1-Tages-Spanne:

$0.77

$0.9899

1-Wochen-Bereich:

$0.75

$1.20

52-Wochen-Spanne:

$0.7015

$7.1988

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Firmenname

60 Degrees Pharmaceuticals Inc

Sektor

Healthcare (1174)

Branche

Biotechnology (678)

Telefon

202-327-5422

Adresse

1025 CONNECTICUT AVENUE NW, WASHINGTON

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SXTP's Discussions on Twitter

Vergleichen Sie SXTP mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SXTP 60 Degrees Pharmaceuticals Inc	0.80	1.84M	502.40K	-7.91M	-4.32M	-9.972
VRTX Vertex Pharmaceuticals Inc	438.40	112.90B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	683.08	75.06B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	665.68	40.45B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	277.16	35.75B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	120.88	28.98B	3.30B	-501.07M	1.03B	-2.1146

60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten

02:21 AM

60 Degrees Pharma Announces Closing of $1.043 Million - GlobeNewswire

02:21 AM

02:20 AM

60 Degrees Pharma Secures Fresh Capital: Inside the $1M Financing Deal That's Turning Heads - StockTitan

02:20 AM

08:30 AM

60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times

Jan 29, 2025

Pharma Company's $1M Cash Injection Comes with Hidden UpsideComplete Analysis - StockTitan

Jan 29, 2025

US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings - Benzinga

Jan 29, 2025

60 Degrees Pharmaceuticals obtains IRB approval for chronic babesiosis therapy trial - Yahoo Finance

Jan 29, 2025

Why F5 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 29, 2025

Jan 28, 2025

60 Degrees Pharmaceuticals Gets Investigational Review Board Approval for Babesiosis Phase 2 Study - Marketscreener.com

Jan 28, 2025

60 Degrees Pharmaceuticals, Inc. Announces the Approval of an Investigational Review Board Commissioned Phase II Clinical Study - Marketscreener.com

Jan 28, 2025

60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis - GlobeNewswire

Jan 28, 2025

Revolutionary Tick-Borne Disease Treatment Gets Green Light: 400,000 Patients Await New Hope - StockTitan

Jan 28, 2025

Jan 21, 2025

Titan Pharma (NASDAQ:TTNP) Stock Quotes, Forecast and News Summary - Benzinga

Jan 21, 2025

Jan 20, 2025

Palatin Technologies Inc (AMEX: PTN) Analysts Expect It Could Climb 93.76% From Current Levels. - Stocks Register

Jan 20, 2025

60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Jumps 0.32 Percent In Recent Trading, What Questions Do You Have? – Stocks Register - Stocks Register

Jan 20, 2025

Weiss Ratings Reiterates Sell (E+) Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World

Jan 20, 2025

Jan 15, 2025